202 related articles for article (PubMed ID: 9142735)
1. Effect of adrenergic receptor ligands on metaiodobenzylguanidine uptake and storage in neuroblastoma cells.
Babich JW; Graham W; Fischman AJ
Eur J Nucl Med; 1997 May; 24(5):538-43. PubMed ID: 9142735
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of phenylpiperazines as targeting agents for neuroblastoma.
Babich JW; Graham WA; Fischman AJ
Br J Cancer; 1996 Sep; 74(6):917-24. PubMed ID: 8826858
[TBL] [Abstract][Full Text] [Related]
3. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.
Smets LA; Loesberg C; Janssen M; Metwally EA; Huiskamp R
Cancer Res; 1989 Jun; 49(11):2941-4. PubMed ID: 2720653
[TBL] [Abstract][Full Text] [Related]
4. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
Vaidyanathan G; Zhao XG; Strickland DK; Zalutsky MR
J Nucl Med; 1997 Feb; 38(2):330-4. PubMed ID: 9025764
[TBL] [Abstract][Full Text] [Related]
5. Biology of metaiodobenzylguanidine interactions with human neuroblastoma cells.
Iavarone A; Lasorella A; Servidei T; Riccardi R; Troncone L; Mastrangelo R
J Nucl Biol Med (1991); 1991; 35(4):186-90. PubMed ID: 1823815
[TBL] [Abstract][Full Text] [Related]
6. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
Vaidyanathan G; Zhao XG; Larsen RH; Zalutsky MR
Br J Cancer; 1997; 76(2):226-33. PubMed ID: 9231923
[TBL] [Abstract][Full Text] [Related]
7. Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH.
Buck J; Bruchelt G; Girgert R; Treuner J; Niethammer D
Cancer Res; 1985 Dec; 45(12 Pt 1):6366-70. PubMed ID: 3864530
[TBL] [Abstract][Full Text] [Related]
8. Release mechanisms of [125I]meta-iodobenzylguanidine in neuroblastoma cells: evidence of a carrier-mediated efflux.
Servidei T; Iavarone A; Lasorella A; Mastrangelo S; Riccardi R
Eur J Cancer; 1995; 31A(4):591-5. PubMed ID: 7576975
[TBL] [Abstract][Full Text] [Related]
9. Extragranular storage of the neuron blocking agent meta-iodobenzylguanidine (MIBG) in human neuroblastoma cells.
Smets LA; Janssen M; Metwally E; Loesberg C
Biochem Pharmacol; 1990 Jun; 39(12):1959-64. PubMed ID: 2353937
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
Smets LA; Janssen M; Rutgers M; Ritzen K; Buttenhuis C
Int J Cancer; 1991 Jun; 48(4):609-15. PubMed ID: 2045205
[TBL] [Abstract][Full Text] [Related]
11. Increase of metaiodobenzylguanidine uptake and intracellular half-life during differentiation of human neuroblastoma cells.
Montaldo PG; Raffaghello L; Guarnaccia F; Pistoia V; Garaventa A; Ponzoni M
Int J Cancer; 1996 Jul; 67(1):95-100. PubMed ID: 8690531
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
13. Distribution and types of adrenoceptors in the guinea-pig ileum: the action of alpha- and beta-adrenoceptor blocking agents.
Bauer V
Br J Pharmacol; 1982 Aug; 76(4):569-78. PubMed ID: 6125224
[TBL] [Abstract][Full Text] [Related]
14. Implications of the uptake of 131I-radiolabelled meta-iodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma.
O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
Br J Radiol; 1991 May; 64(761):428-34. PubMed ID: 2036567
[TBL] [Abstract][Full Text] [Related]
15. Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
Khafagi FA; Shapiro B; Fig LM; Mallette S; Sisson JC
J Nucl Med; 1989 Apr; 30(4):481-9. PubMed ID: 2738677
[TBL] [Abstract][Full Text] [Related]
16. In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells.
Montaldo PG; Carbone R; Lanciotti M; Ponzoni M; Cornaglia-Ferraris P
J Nucl Biol Med (1991); 1991; 35(4):195-8. PubMed ID: 1823817
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine does not interfere with meta-iodobenzylguanidine (MIBG) uptake at clinically relevant concentrations.
Batra V; Makvandi M; Zuppa AF; Patel N; Elias J; Pryma DA; Maris JM
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27654664
[TBL] [Abstract][Full Text] [Related]
18. In vitro therapeutic targeting of neuroblastomas using 125I-labelled meta-iodobenzylguanidine.
Guerreau D; Thedrez P; Fritsch P; Saccavini JC; Metivier H; Nolibe D; Masse R; Coornaert S; Chatal JF
Int J Cancer; 1990 Jun; 45(6):1164-8. PubMed ID: 2351489
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
Weber W; Weber J; Senekowitsch-Schmidtke R
Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
[TBL] [Abstract][Full Text] [Related]
20. Quantitative study of radioiodinated metaiodobenzylguanidine uptake in children with neuroblastoma: correlation with tumor histopathology.
Moyes JS; Babich JW; Carter R; Meller ST; Agrawal M; McElwain TJ
J Nucl Med; 1989 Apr; 30(4):474-80. PubMed ID: 2738676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
